Showing posts with label astellas. Show all posts
Showing posts with label astellas. Show all posts

Thursday, November 3, 2011

MDV1300 Making a Mark While Provenge Takes a Deep Plunge

Today San Francisco-based Medivation, Inc., ($MDVN) saw its stock value scale El Capitan within a day.  This coming on the heels of Dendreon Corp. ($DNDN) losing a huge chunk of its stock value yesterday is a good example of human psychology.  We reward "optimism" over "cautious behavior."  

Tuesday, February 1, 2011

Astellas Oncology: Dora's Estrellas in Astellas' Star-Pocket


Many of you may recall the spring of 2010 when Astellas tried to acquire OSI Pharmaceuticals - the barbs flew, as expected, until tons of Yens (to the tune of $4B) were offered to calm OSI and bring it into the Astelles family.  That event signaled the maturing of Astellas as an oncology firm.